AR.1
The androgen receptor coordinates biosynthesis and proliferation in prostate cancer
 The androgen receptor (AR) is the major therapeutic target in prostate cancer, although the important targets of the AR have remained obscure.  Here we report a detailed genomic profile of AR signalling and find that the AR directly regulates glycolysis, anabolic metabolism and cell cycle regulators in prostate cancer.  This coordinated transcriptional program promotes cancer cell proliferation and enhances the macromolecular synthesis needed to produce daughter cells.     